4.7 Article

Iterative Design and in Vivo Evaluation of an Oncolytic Antilymphoma Peptide

期刊

JOURNAL OF MEDICINAL CHEMISTRY
卷 60, 期 1, 页码 146-156

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.6b00839

关键词

-

资金

  1. Lytix Biopharma AS
  2. Faculty of Health Sciences, UiT - The Arctic University of Norway
  3. Research Council of Norway

向作者/读者索取更多资源

Oncolytic peptides represent a promising new strategy within the field of cancer immunotherapy. Here we describe the systematic design and evaluation of short antilymphoma peptides within this paradigm. The peptides were tested in vitro and in vivo to identify a lead compound for further evaluation as novel oncolytic immunotherapeutic. In vitro tests revealed peptides with high activity against several lymphoma types and low cytotoxicity toward normal cells. Treated lymphoma cells exhibited a reduced mitochondrial membrane potential that resulted in an irreversible disintegration of their plasma membranes. No caspase activation or ultrastructural features of apoptotic cell death were observed. One of these peptides, 11, was shown to induce complete tumor regression and protective immunity following intralesional treatment of murine A20 B-lymphomas. Due to its selectivity for lymphoma cells and its ability to induce tumor-specific immune responses, 11 has the potential to be used in intralesional treatment of accessible lymphoma tumors.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Chemistry, Multidisciplinary

Very Short and Stable Lactoferricin-Derived Antimicrobial Peptides: Design Principles and Potential Uses

John S. Mjoen Svendsen, Thomas M. Grant, David Rennison, Margaret A. Brimble, Johan Svenson

ACCOUNTS OF CHEMICAL RESEARCH (2019)

Article Biochemical Research Methods

Preparation and Assessment of Self-Immolative Linkers for Therapeutic Bioconjugates with Amino- and Hydroxyl-Containing Cargoes

Myagmarsuren Sengee, J. Johannes Eksteen, Silje Lillemark Nergard, Terje Vasskog, Leiv K. Sydnes

BIOCONJUGATE CHEMISTRY (2019)

Article Oncology

Tumor lysis with LTX-401 creates anticancer immunity

Wei Xie, Laura Mondragon, Brynjar Mauseth, Yan Wang, Jonathan Pol, Sarah Levesque, Heng Zhou, Takahiro Yamazaki, Johannes J. Eksteen, Laurence Zitvogel, Baldur Sveinbjornsson, Oystein Rekdal, Oliver Kepp, Guido Kroemer

ONCOIMMUNOLOGY (2019)

Article Chemistry, Medicinal

Antimicrobial activity of amphipathic α,α-disubstituted β-amino amide derivatives against ESBL - CARBA producing multi-resistant bacteria; effect of halogenation, lipophilicity and cationic character

Marianne H. Paulsen, Dominik Ausbacher, Annette Bayer, Magnus Engqvist, Terkel Hansen, Tor Haug, Trude Anderssen, Jeanette H. Andersen, Johanna U. Ericson Sollid, Morten B. Strom

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Chemistry, Multidisciplinary

Selective Intracellular Delivery of Thiolated Cargo to Tumor and Neovasculature Cells Using Histidine-Rich Peptides as Vectors

J. Johannes Eksteen, Dominik Ausbacher, Terje Vasskog, Oystein Rekdal, John S. M. Svendsen

ACS OMEGA (2020)

Article Chemistry, Medicinal

Amphipathic Barbiturates as Mimics of Antimicrobial Peptides and the Marine Natural Products Eusynstyelamides with Activity against Multi-resistant Clinical Isolates

Marianne H. Paulsen, Magnus Engqvist, Dominik Ausbacher, Trude Anderssen, Manuel K. Langer, Tor Haug, Glenn R. Morello, Laura E. Liikanen, Hans-Matti Blencke, Johan Isaksson, Eric Juskewitz, Annette Bayer, Morten B. Strom

Summary: This study presents a series of synthetic cationic amphipathic barbiturates with potent antimicrobial activity against multi-resistant bacteria. Inspired by the pharmacophore model of small antimicrobial peptides and marine antimicrobials, these compounds show promising in vivo antibiotic efficacy and strong membrane disruptive effects. The results suggest that the design strategy based on small AMPs and marine compounds can lead to the development of highly effective peptidomimetics against multi-drug resistant bacteria.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Infectious Diseases

Lactoferricin-inspired peptide AMC-109 augments the effect of ciprofloxacin against Pseudomonas aeruginosa biofilm in chronic murine wounds

Anne Sofie Laulund, Franziska Angelika Schwartz, Lars Christophersen, Niels Hoiby, John Sigurd Mjoen Svendsen, Wenche Stensen, Kim Thomsen, Jorunn Pauline Cavanagh, Claus Moser

Summary: This study aimed to investigate whether adjunctive AMC-109 could augment the ciprofloxacin effect in a chronic Pseudomonas aeruginosa wound model. The results showed that the combined treatment group had a lower bacterial load, decreased pro-inflammatory response, and improved tissue remodeling.

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2022)

Article Infectious Diseases

Anti-Colonization Effect of Au Surfaces with Self-Assembled Molecular Monolayers Functionalized with Antimicrobial Peptides on S. epidermidis

Eskil Andre Karlsen, Wenche Stensen, Eric Juskewitz, Johan Svenson, Mattias Berglin, John Sigurd Mjoen Svendsen

Summary: The study demonstrated that antimicrobial peptides covalently attached to a gold surface can effectively reduce bacterial colonization, offering promising strategies for combating healthcare-associated infections.

ANTIBIOTICS-BASEL (2021)

Article Chemistry, Medicinal

Novel DYRK1A Inhibitor Rescues Learning and Memory Deficits in a Mouse Model of Down Syndrome

Wenche Stensen, Ulli Rothweiler, Richard Alan Engh, Melissa R. Stasko, Ilya Bederman, Alberto C. S. Costa, Anders Fugelli, John S. Mjoen Svendsen

Summary: Down syndrome is a complex genetic disorder with substantial physical, cognitive, and behavioral challenges. While treatment options for physical co-morbidities have improved, cognitive deficits in individuals with DS cannot be addressed pharmacologically, and all individuals with DS develop early onset Alzheimer's disease pathology by the age of 40. The study introduces a novel inhibitor for the protein kinase DYRK1A, which is a key controlling kinase associated with DS.

PHARMACEUTICALS (2021)

Article Multidisciplinary Sciences

The marine natural product mimic MPM-1 is cytolytic and induces DAMP release from human cancer cell lines

Susannah von Hofsten, Marianne Hagensen Paulsen, Synnove Norvoll Magnussen, Dominik Ausbacher, Mathias Kranz, Annette Bayer, Morten B. Strom, Gerd Berge

Summary: Bioprospecting contributes to the discovery of new molecules with anticancer properties. In this study, a new natural product mimic called MPM-1 was found to rapidly kill cancer cells and induce the release of DAMPs, suggesting its potential as a novel anticancer compound.

SCIENTIFIC REPORTS (2022)

Article Pharmacology & Pharmacy

Amphipathic barbiturates as marine product mimics with cytolytic and immunogenic effects on head and neck squamous cell carcinoma cell lines

Susannah von Hofsten, Manuel K. Langer, Katja Korelin, Synnove Magnussen, Dominik Ausbacher, Trude Anderssen, Tuula Salo, Morten B. Strom, Annette Bayer, Ahmed Al-Samadi, Gerd Berge

Summary: This study explores the anticancer activity of a panel of novel compounds (marine product mimics, MPMs) against head and neck squamous cell carcinoma (HNSCC) cell lines. The results indicate that these novel MPMs are more potent than the previously reported MPM-1 and can activate the integrated stress response associated with immunogenic cell death. Cell surface expression of calreticulin and release of HMGB1 and ATP, hallmarks of immunogenic cell death, were also demonstrated. The MPMs show potential as interesting candidates for future HNSCC cancer therapies.

FRONTIERS IN PHARMACOLOGY (2023)

Article Multidisciplinary Sciences

Lateral membrane organization as target of an antimicrobial peptidomimetic compound

Adela Melcrova, Sourav Maity, Josef Melcr, Niels A. W. de Kok, Mariella Gabler, Jonne van der Eyden, Wenche Stensen, John S. M. Svendsen, Arnold J. M. Driessen, Siewert J. Marrink, Wouter H. Roos

Summary: This study investigates the mechanism of action of the antimicrobial cationic tripeptide AMC-109. It was found that AMC-109 self-assembles into stable aggregates with a cationic surface, and then inserts into the bacterial membrane disrupting membrane nanodomains, thus affecting membrane function without forming pores. The results suggest that AMC-109 is a peptide with enhanced selectivity for bacterial membranes.

NATURE COMMUNICATIONS (2023)

Article Biochemistry & Molecular Biology

Goldilocks Dilemma: LPS Works Both as the Initial Target and a Barrier for the Antimicrobial Action of Cationic AMPs on E. coli

Martin Jakubec, Fredrik G. Rylandsholm, Philip Rainsford, Mitchell Silk, Maxim Bril'kov, Tone Kristoffersen, Eric Juskewitz, Johanna U. Ericson, John Sigurd M. Svendsen

Summary: Antimicrobial peptides (AMPs) are compounds that disrupt bacterial membranes. The initial interaction between AMPs and Gram-negative E. coli is driven by lipopolysaccharides (LPS) which act as kinetic barriers. Cationic AMPs first bind to LPS before reaching the bacterial membrane. The potency of AMPs is diminished if the initial LPS-binding is too strong, while their antimicrobial activity is dependent on effective interaction with the membrane.

BIOMOLECULES (2023)

暂无数据